BPC-157 + GHK-Cu + TB-500
BPC-157 + GHK-Cu + TB-500
- 10 mg + 50 mg + 10 mg (70 mg total)
$195.00
Documentation pending
BPC-157 + TB-500
Co-formulated blend: BPC-157 (synthetic pentadecapeptide) and TB-500 (synthetic thymosin beta-4 fragment)
- SKU family:
- BB
- Format:
- Lyophilised powder, sealed glass vial
Two-component lyophilised blend with each nominal fill stated separately.
$100.00
Availability pending
1
Research use only. For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use, diagnostic use, or any form of administration.
No published batch record for this material yet.
Overview
A co-formulated research blend containing BPC-157 and TB-500. Both chemical identities and both nominal fills are stated on the label, in the batch record, and on this page.
Research
Blend of two independently characterised synthetic peptides. Component ratio is fixed at the stated nominal fills.
Tissue and matrix peptides: what the preclinical record shows
BPC-157, thymosin beta-4 fragments, and GHK-Cu are studied almost entirely in in vitro and rodent systems. This overview separates that record from clinical evidence.
Last reviewed 2026-08-14 · Research content reviewer, Batch One
Documentation
No published batch record exists for this material yet. We do not state identity, purity, mass, sterility, or endotoxin status without a report for the exact lot.
FAQ
Related materials
BPC-157 + TB-500 + KPV
BPC-157 + TB-500 + KPV
- 10 mg + 10 mg + 10 mg (30 mg total)
$127.00
Documentation pending
CJC-1295 without DAC + Ipamorelin
Co-formulated blend: CJC-1295 without DAC (modified GRF 1-29) and Ipamorelin (synthetic pentapeptide secretagogue)
- 5 mg + 5 mg (10 mg total)
$112.00
Documentation pending
GHK-Cu + KPV
GHK-Cu + KPV
- 50 mg + 10 mg (60 mg total)
- 100 mg + 10 mg (110 mg total)
$77.00
Documentation pending
BPC-157 + TB-500 · 5 mg + 5 mg (10 mg total)
$100.00